The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-3-(1H-imidazol-2-yl)-1-(4-((tetrahydro-2H-pyran-2-yl)oxy)phenyl)prop-2-en-1-one ID: ALA4585640
Chembl Id: CHEMBL4585640
PubChem CID: 18782952
Max Phase: Preclinical
Molecular Formula: C17H18N2O3
Molecular Weight: 298.34
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(/C=C/c1ncc[nH]1)c1ccc(OC2CCCCO2)cc1
Standard InChI: InChI=1S/C17H18N2O3/c20-15(8-9-16-18-10-11-19-16)13-4-6-14(7-5-13)22-17-3-1-2-12-21-17/h4-11,17H,1-3,12H2,(H,18,19)/b9-8+
Standard InChI Key: PSPBCDJPGZTQAR-CMDGGOBGSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 298.34Molecular Weight (Monoisotopic): 298.1317AlogP: 3.21#Rotatable Bonds: 5Polar Surface Area: 64.21Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.71CX Basic pKa: 6.44CX LogP: 2.74CX LogD: 2.70Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.68Np Likeness Score: -0.18
References 1. Omar AM, David T, Pagare PP, Ghatge MS, Chen Q, Mehta A, Zhang Y, Abdulmalik O, Naghi AH, El-Araby ME, Safo MK.. (2019) Structural modification of azolylacryloyl derivatives yields a novel class of covalent modifiers of hemoglobin as potential antisickling agents., 10 (11): [PMID:32206236 ] [10.1039/C9MD00291J ]